Hepatocellular Carcinoma Global Industry Opportunities Strategies and Growth Drivers Clinical Trials Review, H1, 2016

The report ” Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016 “, has been prepared based on an in-depth market analysis with inputs from industry experts.

GlobalData’s clinical trial report, Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016″ provides an overview of Hepatocellular Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatocellular Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Download Sample copy of this Report @



– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Reasons to buy

– Assists in formulating key business strategies with regards to investment

– Helps in identifying prominent locations for conducting clinical trials which saves time and cost

– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

– Supports understanding of trials count and enrollment trends by country in global therapeutics market

– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

– Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse All reports Of this Category: www.marketresearchreports.biz/category/38

Table of Content :

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Hepatocellular Carcinoma to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Hepatocellular Carcinoma to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Hepatocellular Carcinoma Therapeutics Clinical Trials 28

Prominent Drugs 29

Latest Clinical Trials News on Hepatocellular Carcinoma 30

May 19, 2016: Incyte Highlights Capmatinib Abstracts to be Presented at the 2016 ASCO Annual Meeting 30

May 18, 2016: Eli Lilly to Present data on VEGF Receptor 2 antagonist ramucirumab at ASCO 30

May 18, 2016: Lilly to present data on TGF small-molecule kinase inhibitor galunisertib at ASCO 31

May 12, 2016: CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase 2 Clinical Trial With ENMD-2076 For Fibrolamellar Carcinoma (FLC) 32

May 04, 2016: RedHill Biopharma Announces National Cancer Institute Grant Supporting YELIVA Phase II Hepatocellular Carcinoma Study 32

May 04, 2016: Phase III Trial of Regorafenib in Patients with Unresectable Liver Cancer Meets Primary Endpoint of Improving Overall Survival 33

Apr 26, 2016: Celsion Announces Enrollment of First Patient in the OPTIMA Study in China 34

Apr 18, 2016: Onxeo Final Data from Mechanistic Livatag Study Show Preferential Affinity for Liver, Support Use as Advanced HCC Treatment 35

Apr 15, 2016: Conatus Poster at EASL Meeting Today Addresses Safety of Caspase Inhibition in Cancer Treatment 35

Apr 04, 2016: Onxeo announces positive DSMB recommendation to continue Livatag ReLive study in HCC 36

Mar 29, 2016: SillaJen Enrolls First U.S. Patient in Multinational Phase 3 Trial for Pexa-Vec in Advanced Liver Cancer 36

Mar 22, 2016: Daiichi Sankyo and ArQule Announce Continuation of METIV-HCC Phase 3 Study of Tivantinib in Second-Line Hepatocellular Carcinoma 37

Mar 16, 2016: Onxeo Poster Demonstrating Unique Livatag Mechanism of Action Accepted for Presentation at AACR Annual Meeting 37

Mar 07, 2016: Major Liver Cancer Study Completes Palliative Cohort Enrolment 38

Mar 07, 2016: Celsion Announces Launch of the OPTIMA Study in China 38

Clinical Trial Profile Snapshots 40

Appendix 1044

Abbreviations 1044

Definitions 1044

Research Methodology 1045

Secondary Research 1045

About GlobalData 1046

Contact Us 1046

Disclaimer 1046

Source 1047

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact us:

Mr. Nachiket

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA: Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/

E : sales@marketresearchreports.biz